Ventracor Limited

 
 
    

View in Other Languages

News

Australian Market Report of March 20: Investors Digested Recent Rallies

🕔3/20/2009 1:15:02 PM 14163

Yesterday Australian shares closed 1% higher as most sectors surged. The benchmark S&P/ASX200 index rose 33.9 points, at 3480.2 while the All Ordinaries index was up 0.9%, or 30.60 points, at 3416.8. The local mining and energy sectors could be buoyed by the rising gold and oil prices today despite the negative lead from the US.

Read Full Article

Ventracor Limited (ASX:VCR) Views The Article in "The Australian" Newspaper As Incorrect And Misleading

🕔2/18/2009 11:50:42 AM 7319

Ventracor Limited (ASX:VCR)(PINK:VTCRY) is responding to an article that appeared in today's "The Australian" newspaper, which in the Company's view makes incorrect and misleading allegations regarding the Company and its product the VentrAssist(R) Left Ventricular Assist Device (LVAD).

Read Full Article

Ventracor Limited (ASX:VCR) Announce 250th Implant of VentrAssist Left Ventricular Assist Device (LVAD)

🕔5/6/2008 2:59:16 PM 6581

Ventracor Limited (ASX:VCR)(US:VTCRY) today announced that there have now been more than 250 patient implants of the VentrAssist(R) Left Ventricular Assist Device (LVAD).

Read Full Article

Ventracor Limited (ASX:VCR) Announce Results of US Feasibility Trial of the VentraAssist LVAD

🕔4/14/2008 12:56:20 PM 6385

Ventracor Limited (ASX:VCR)(US:VTCRY) today released the clinical results of the US Feasibility Trial of the VentrAssist(R) Left Ventricular Assist Device (LVAD). The results were presented on Saturday 12 April at the annual meeting of the International Society of Heart and Lung Transplantation (ISHLT) in Boston by Dr. Andrew Boyle, Assistant Professor of Medicine at the University of Minnesota Medical School, in Minneapolis MN.

Read Full Article

Ventracor Limited (ASX:VCR) CEO Peter Crosby Letter to Shareholders

🕔4/3/2008 1:55:54 PM 8503

Ventracor Limited (ASX: VCR)(PNK: VTCRY) CEO, Peter Crosby Letter to Shareholders

Read Full Article

Ventracor Limited (ASX:VCR) Announce Election of John Ward to Chairman

🕔4/3/2008 10:51:25 AM 10754

Ventracor Limited (ASX: VCR)(PNK: VTCRY) announced today changes to the Board of Directors. John Massey has retired as a Director and Chairman of the Board. John Ward has been elected Chairman of the Board of Directors, and William Curran takes on the role of Chairman of the Audit, Risk and Compliance Committee.

Read Full Article

Ventracor (ASX:VCR) Announce US FDA Unconditional Approval of Destination Therapy Trial For LVAD

🕔3/17/2008 9:52:43 AM 6301

Ventracor Limited (ASX: VCR)(ADR: VTCRY) announced today that the US Food and Drug Administration (FDA) has granted unconditional approval for the US Destination Therapy Trial of the VentrAssist Left Ventricular Assist Device (LVAD).

Read Full Article

Ventracor Limited (ASX:VCR) Appoints Destination Therapy Trial Principal Investigator For LVAD

🕔3/13/2008 11:13:21 AM 5203

Ventracor (ASX: VCR) announced today the appointment of Professor Mariell Jessup as Cardiology Principal Investigator of the US Destination Therapy Trial of the VentrAssist Left Ventricular Assist Device (LVAD).

Read Full Article

Ventracor Limited (ASX:VCR) Announces 200th VentraAssist LVAD (Left Ventricular Assist Device) Implant

🕔2/11/2008 2:09:27 PM 5174

Ventracor (ASX: VCR) has implanted the 200th patient with its VentrAssist(tm) Left Ventricular Assist Device (LVAD)

Read Full Article

Ventracor (ASX:VCR) Announces European Approval for New Version VentrAssist LVAD

🕔12/19/2007 9:42:10 AM 3500

Ventracor (ASX: VCR) today announced CE Marking approval for the next version of the VentrAssist(tm) left ventricular assist device (LVAD) which allows it to be marketed and sold in Europe.

Read Full Article
###

42,471 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 28) (Last 30 Days: 147) (Since Published: 15570) 

Company Data

    Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Healthcare